| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/09/2002 | US6368612 Insertable device |
| 04/09/2002 | US6368606 Cosmetic composition for the treatment of keratinous materials comprising at least a grafted silicone polymer and at least an aqueous dispersion of insoluble particles of non ionic or cationic polymer |
| 04/09/2002 | US6368602 Mucosal immunization against hepatitis A virus (HAV) through rectal administration of HAV vaccine |
| 04/09/2002 | US6368595 Forming a formulation comprising protease enzyme and polyvinyl alcohol film forming agent, topically applying the formulation, incubating to form a film incorporating enzyme, removing the film incorporating the enzyme from the site |
| 04/09/2002 | US6368594 Pure polypeptide |
| 04/09/2002 | US6368586 Surface treatment; exposure of polymer to metal compound; sustained drug release |
| 04/09/2002 | US6367479 Method of forcing the reverse transport of cholesterol from a body part to the liver while avoiding harmful disruptions of hepatic cholesterol homeostasis, and pharmaceutical compositions and kit related thereto |
| 04/09/2002 | CA2249744C Oral peptide pharmaceutical products |
| 04/09/2002 | CA2141691C Solid pharmaceutical dosage forms having an extended two-stage release profile and production thereof |
| 04/09/2002 | CA2115648C Osmotic drug delivery devices with hydrophobic wall materials |
| 04/09/2002 | CA2026384C A solid drug form with a high verapamil content |
| 04/09/2002 | CA1341356C Transkaryotic implantation |
| 04/04/2002 | WO2002026845A1 Aqueous polymer dispersion |
| 04/04/2002 | WO2002026716A2 Benzimidazoles and methods for use thereof in the treatment of cancer or viral infections |
| 04/04/2002 | WO2002026372A2 Instant water dissolvable encapsulate and process |
| 04/04/2002 | WO2002026371A2 Apparatus and method for preparing microparticles using liquid-liquid extraction |
| 04/04/2002 | WO2002026324A2 Tocol-based compositions containing amiodarone |
| 04/04/2002 | WO2002026282A2 Fluid delivery device with light activated energy source |
| 04/04/2002 | WO2002026279A1 E-ptfe foil impregnated with an encapsulated bioactive substance |
| 04/04/2002 | WO2002026277A2 Stabilized hydrogen peroxide solutions |
| 04/04/2002 | WO2002026264A1 Oral delivery method and composition for solid medications or dietary supplements in the form of solid particles |
| 04/04/2002 | WO2002026263A2 Stable solid dosage forms of amino acids and processes for producing same |
| 04/04/2002 | WO2002026262A2 Compositions for reducing side effects in chemotherapeutic treatments |
| 04/04/2002 | WO2002026241A1 Polymeric micelle containing cisplatin enclosed therein and use thereof |
| 04/04/2002 | WO2002026238A1 Phosphate derivative supplements |
| 04/04/2002 | WO2002026237A1 Liquid prednisolone sodium phosphate preparation |
| 04/04/2002 | WO2002026235A1 Dispersible pharmaceutical cephalosporin compositions, preparation and use thereof |
| 04/04/2002 | WO2002026234A1 Eye drops comprising acyclovir suspension |
| 04/04/2002 | WO2002026232A1 Pharmaceutical composition for transmucosal delivery of a dihydroergotamine/metoclopramide combination |
| 04/04/2002 | WO2002026217A2 Composition for the transdermal delivery of fentanyl |
| 04/04/2002 | WO2002026216A1 Pharmaceutical oxan preparation |
| 04/04/2002 | WO2002026215A2 Thermogelling biodegradable aqueous polymer solution |
| 04/04/2002 | WO2002026214A1 Ion-strength independent sustained release pharmaceutical formulation |
| 04/04/2002 | WO2002026213A1 Pharmaceutical composition containing psyllium fiber and a lipase inhibitor |
| 04/04/2002 | WO2002026212A2 Microparticle compositions and methods for the manufacture thereof |
| 04/04/2002 | WO2002026211A1 Topical polymeric antimicrobial emulsion |
| 04/04/2002 | WO2002026210A2 Proton pump inhibitor formulation |
| 04/04/2002 | WO2002026209A2 Microparticles for delivery of the heterologous nucleic acids |
| 04/04/2002 | WO2002026208A2 Emulsion vehicle for poorly soluble drugs |
| 04/04/2002 | WO2002026191A2 Methods, compositions and devices utilizing stinging cells/capsules for delivering a therapeutic or a cosmetic agent into a tissue |
| 04/04/2002 | WO2002026040A1 Irreversible coating particles and compositions containing these particles |
| 04/04/2002 | WO2002004012A8 Anhydrous pharmaceutical composition of vancomycin for topical use |
| 04/04/2002 | WO2002003961B1 Microspheres and adjuvants for dna vaccine delivery |
| 04/04/2002 | WO2002002084A8 Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture |
| 04/04/2002 | WO2002000251A9 Vaccine against foot-and-mouth disease |
| 04/04/2002 | WO2001098327A3 Glycopeptide carboxy-saccharide derivatives |
| 04/04/2002 | WO2001098326A3 Glycopeptide disulfide and thioester derivatives |
| 04/04/2002 | WO2001097837A8 Solubilised protein vaccines |
| 04/04/2002 | WO2001097795A3 Systems and methods for treating a mucosal surface |
| 04/04/2002 | WO2001096450A3 Fast cure film forming formulation |
| 04/04/2002 | WO2001087277A3 Method of manufacturing particles |
| 04/04/2002 | WO2001085184A3 Nontoxic vernix compositions and method of producing |
| 04/04/2002 | WO2001085142A8 Compositions and methods for protecting cells during cancer chemotherapy and radiotherapy |
| 04/04/2002 | WO2001080830A3 Pharmacotherapeutic process and composition for central nervous system disorders |
| 04/04/2002 | WO2001056540A3 Device for applying active principles for pharmaceutical or cosmetic purposes |
| 04/04/2002 | WO2001048231A3 Method of achieving persistent transgene expression |
| 04/04/2002 | WO2001012232A3 Process to make a sustained release formulation |
| 04/04/2002 | WO2000058359A9 Retro-inverso prosaposin-derived peptides and use thereof |
| 04/04/2002 | US20020040203 Method for transdermal or intradermal delivery of molecules |
| 04/04/2002 | US20020040139 Intranasal formulations for treating sexual disorders |
| 04/04/2002 | US20020040128 Carbohydrate-blood protein complex for us as an oxygen transporter |
| 04/04/2002 | US20020040064 Administering agent that inhibits the contraction or migration of smooth muscle cells; sustained dosage; biological stents |
| 04/04/2002 | US20020040063 Liquid formulation of metformin |
| 04/04/2002 | US20020040061 Compounds such as 1-(3-(2-hydroxybenzoylamino)propyl)-2-pyrrolidinone; dosage forms of bioactive agents or drugs |
| 04/04/2002 | US20020040051 Solid dispersion of ipriflavone for oral administration and its manufacturing methods |
| 04/04/2002 | US20020040042 Inhibition of noninactivating Na channels of mammalian optic nerve as a means of preventing optic nerve degeneration associated with glaucoma |
| 04/04/2002 | US20020040012 A synthetic pentasaccharide which is a selective inhibitor of faxtor xa, acting via antithrombin III |
| 04/04/2002 | US20020040004 Administering to mammal a mixture of proteins derived from ground bone to provide increased blood flow to tissue served by an occluded or partly occluded vessel |
| 04/04/2002 | US20020039996 Pharmaceutical administration form for peptides, process for its preparation, and use |
| 04/04/2002 | US20020039601 Cancer cell growth suppressor and cell differentiation inducer and method for manufacturing the same |
| 04/04/2002 | US20020039599 Calibration; administering antiseptic compound |
| 04/04/2002 | US20020039598 Stabilized pharmaceutical composition and its production |
| 04/04/2002 | US20020039597 Stabilized compositions containing benzimidazole-type compounds |
| 04/04/2002 | US20020039596 Sustained release; emulsification, desolventizing |
| 04/04/2002 | US20020039595 Capsule dosage units |
| 04/04/2002 | US20020039594 Solid porous matrices and methods of making and using the same |
| 04/04/2002 | US20020039592 Methods compositions and devices utilizing stinging cells/capsules for delivering a therapeutic or a cosmetic agent into a tissue |
| 04/04/2002 | US20020039590 Nontoxic vernix compositions and method of producing |
| 04/04/2002 | US20020039582 Using antigen; oil in water emulsion |
| 04/04/2002 | US20020039560 Drug delivery |
| 04/04/2002 | US20020039556 Stabilised phospholipid compositions |
| 04/04/2002 | DE10045380A1 Verfahren zur Kontrazeption und dessen Darreichungsform Method of contraception and its dosage form |
| 04/04/2002 | DE10044846A1 Mittel mit verlängerter Magenverweilzeit zur Erzeugung eines langanhaltenden Sättigungseffektes sowie dessen Verwendung Agent with a prolonged gastric residence to produce a long-lasting satiation effect and its use |
| 04/04/2002 | DE10044635A1 Transparente Wirkstoffkapseln Transparent drug capsules |
| 04/04/2002 | DE10044545A1 Retardpartikeldispersion Retardpartikeldispersion |
| 04/04/2002 | CA2426666A1 Ion-strength independent sustained release pharmaceutical formulation |
| 04/04/2002 | CA2424949A1 Pharmaceutical oxan preparation |
| 04/04/2002 | CA2423484A1 Instant water dissolvable encapsulate and process |
| 04/04/2002 | CA2423201A1 Stabilized hydrogen peroxide solutions |
| 04/04/2002 | CA2422916A1 Compounds and methods for use thereof in the treatment of cancer or viral infections |
| 04/03/2002 | EP1192961A2 Solid preparation for dialysis and process for producing the same |
| 04/03/2002 | EP1192960A1 Solid preparation for dialysis and process for producing the same |
| 04/03/2002 | EP1192947A1 Pharmaceutical composition comprising trehalose for ophthalmic use |
| 04/03/2002 | EP1192946A1 Use of mometasone furoate for treating airway passage and lung diseases |
| 04/03/2002 | EP1192942A2 Base material for dry direct tableting comprising low-substituted hydroxypropyl cellulose |
| 04/03/2002 | EP1192938A2 Composition to enhance permeation of topical skin agents |
| 04/03/2002 | EP1192248A1 Antisense modulation of ship-2 expression |
| 04/03/2002 | EP1192170A1 Propargyl phenyl ether a2a receptor agonists |
| 04/03/2002 | EP1192134A2 Processes for the preparation of (r)-g(a)-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenyl)ethyl)-4-piperidinemethanol |
| 04/03/2002 | EP1191999A1 Method of particle formation |